KS
Koukuntla Srinivas Reddy
About Koukuntla Srinivas Reddy
Data last updated:
Koukuntla Srinivas Reddy has 6 years in corporate governance. Holds Whole-Time Director role. Currently with 2 companies, including Vals Pharma Private Limited and Viyana Drugs Private Limited. Formerly with 1 company, such as Amtec Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 29 May 2023 | 2023 | – | Under Process Of Striking Off | |
| Whole-Time Director | 11 May 2020 | 2020 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 03 Oct 2023 | 2023 | – | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Koukuntla Srinivas Reddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Koukuntla Srinivas Reddy
Koukuntla Srinivas Reddy has 6 years in corporate governance. Holds Whole-Time Director role. Currently with 2 companies, including Vals Pharma Private Limited and Viyana Drugs Private Limited. Formerly with 1 company, such as Amtec Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Koukuntla Srinivas Reddy is associated with 2 companies as Whole-Time Director, including Viyana Drugs Private Limited, Vals Pharma Private Limited.
Koukuntla Srinivas Reddy has expertise in General Business.
Koukuntla Srinivas Reddy has 6 years in corporate governance.
Koukuntla Srinivas Reddy currently holds positions at 2 companies: Viyana Drugs Private Limited, Vals Pharma Private Limited.